A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the CSNK2A1 Gene in a Turkish Patient
dc.authorid | Gürkan, Hakan/0000-0002-8967-6124 | |
dc.authorid | ZHURI, DRENUSHE/0000-0002-8370-1990 | |
dc.authorwosid | Gürkan, Hakan/AAF-2866-2020 | |
dc.contributor.author | Zhuri, Drenushe | |
dc.contributor.author | Dusenkalkan, Fulya | |
dc.contributor.author | Tunca Alparslan, Guzin | |
dc.contributor.author | Gurkan, Hakan | |
dc.date.accessioned | 2024-06-12T11:09:06Z | |
dc.date.available | 2024-06-12T11:09:06Z | |
dc.date.issued | 2023 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Introduction: Okur-Chung neurodevelopmental syndrome (OCNDS; #617062) has been associated with heterozygous mutations in the CSNK2A1 gene (*115440) mapped on the chromosome's 20p13 region. Case Presentation: The analysis was performed on a 2-year-old patient who was admitted to our genetic diseases evaluation center by his family with a complaint of hypotonia. We detected a heterozygous NM_177559.3 (CSNK2A1):c.1139_1140dupGG (p.Met381GlyfsTer32) variant in the CSNK2A1 gene from a whole-exome sequence analysis. Conclusion: The variant that we detected has not been reported in open-access databases to date, so it was evaluated as a novel likely pathogenic variant according to the ACMG-2015 criteria. No variant was detected upon segregation analysis of the patient's parents; therefore, the related variant was evaluated as de novo. In this study, we offer the first report of a pathogenic frameshift variant in the CSNK2A1 gene that has a relationship with OCNDS. | en_US |
dc.identifier.doi | 10.1159/000530585 | |
dc.identifier.endpage | 50 | en_US |
dc.identifier.issn | 1661-8769 | |
dc.identifier.issn | 1661-8777 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 38357263 | en_US |
dc.identifier.scopus | 2-s2.0-85185781863 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 43 | en_US |
dc.identifier.uri | https://doi.org/10.1159/000530585 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22687 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | WOS:001008104400001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.relation.ispartof | Molecular Syndromology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurodevelopmental Syndrome | en_US |
dc.subject | Hypotonia | en_US |
dc.subject | Novel | en_US |
dc.subject | De Novo Variant | en_US |
dc.subject | Whole-Exome Sequencing | en_US |
dc.subject | Protein-Kinase Ck2 | en_US |
dc.subject | Abnormalities | en_US |
dc.subject | Prediction | en_US |
dc.title | A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the CSNK2A1 Gene in a Turkish Patient | en_US |
dc.type | Article | en_US |